ESP / ENG

About the response against AIDS, TB and Malaria

Stop TB Partnership and Johnson & Johnson, with support fromUSAID and The Global Fund, Announce Price Reduction for bedaquiline for Treatment of DR-TB in Low- and Middle-Income Countries

Source: http://www.stoptb.org Joint efforts aim to accelerate scale-up of WHO-recommended all-oral treatment regimens – a transition urgently needed to help protect the health of people with drug resistant-tuberculosis who are particularly vulnerable during COVID-19...
Read More

Continued availability and affordability of life-saving tools critical to avoid doubling of malaria deaths this year and win global fight against the disease

Source: https://endmalaria.org Geneva, 19 June 2020 — In conjunction with the annual Rapid Diagnostic Test (RDT) Suppliers Forum convened by the World Health Organization (WHO) this week, the RBM Partnership to End Malaria is calling on governments, manufacturers...
Read More

UNAIDS report on the global AIDS epidemic shows that 2020 targets will not be met because of deeply unequal success; COVID-19 risks blowing HIV progress way off course

Source: https://www.unaids.org Missed targets have resulted in 3.5 million more HIV infections and 820 000 more AIDS-related deaths since 2015 than if the world was on track to meet the 2020 targets. In addition, the response could be set back further, by 10 years or...
Read More

UNAIDS Executive Director sets out HIV/COVID-19 landscape at opening of PCB meeting

Source: UNAIDS GENEVA, 24 June 2020—The 46th meeting of the UNAIDS Programme Coordinating Board commenced on 23 June 2020. Held for the first time as a virtual meeting, as a result of the COVID-19 pandemic, the meeting will see three days of discussion and...
Read More